The largest database of trusted experimental protocols

Microscan autoscan 4 system

Manufactured by Beckman Coulter
Sourced in United States

The MicroScan autoSCAN-4-System is an automated in vitro diagnostic device for the identification and susceptibility testing of bacterial isolates. The system performs automated broth microdilution susceptibility testing and identification of a wide range of clinically relevant bacteria.

Automatically generated - may contain errors

6 protocols using microscan autoscan 4 system

1

Bacterial and Fungal Identification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Secondary infections were identified by clinical assessment. Nutrient agar, blood agar, MacConkey agar and Sabouraud dextrose agar were used for bacterial and fungal culture. Microscopy and biochemical assays were carried out to identify microbial species. Antibiotic susceptibility testing from identified species were performed using the semi-automatic analyser Microscan Autoscan-4 system (Beckman Coulter, Indianapolis, IN, USA). The antibiotics tested were ampicillin, azithromycin, cefoxitin, ciprofloxacin, erythromycin, fosfomycin, fusidic acid and gentamicin. All the laboratory analyses for microbial identification were carried out at King Abdulaziz Centre for Science and Technology (KACST).
+ Open protocol
+ Expand
2

Comprehensive Antibiotic Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kirby–Bauer disk diffusion was performed using the 0.5 McFarland standard of bacteria suspension seeded into Mueller–Hinton agar plates. The antibiotics tested included ampicillin (10 µg), cefotaxime (30 µg), norfloxacin (10 µg), ceftazidime (30 µg), ertapenem (10 µg), cefoxitin (30 µg) and cefuroxime (30 µg). The measured zone sizes were interpreted according to the Clinical and Laboratory Standard (CLSI, M100, 26th ed, 2018) guidelines (CLSI 2018). P. aeruginosa was tested against gentamicin (10 µg), cefepime (30 µg), ceftazidime (30 µg), ciprofloxacin (5 µg), piperacillin tazobactam (110 µg), amikacin (30 µg) and meropenem (10 µg). Pseudomonas stutzeri and Acinetobacter spp. were tested against 11 antibiotics in a microbroth dilution using the MicroScan autoSCAN-4-System with the NC 66 panel (Beckman Coulter Life Sciences, Indianapolis, IN, USA) following the manufacturer’s instructions. K. pneumoniae ATCC 700603 and E. coli ATCC 25922 were used as control strains in the evaluation of the performance of the tests. An MDR phenotype was defined as non-susceptibility to ≥1 agent in ≥3 antimicrobial categories [46 (link)]. Isolates with non-susceptibility to 3rd-generation cephalosporins were examined for the possible presence of AmpCs and ESBLs according to the CLSI guideline.
+ Open protocol
+ Expand
3

Antibiotic Resistance Screening in ESBL-Producing Enterobacteriaceae

Check if the same lab product or an alternative is used in the 5 most similar protocols
For all 19 ESBL-producing Enterobacteriaceae from irrigation water, resistance to 32 clinically relevant antibiotics was determined in disk diffusion assays as described previously [15 (link)]. Additionally, all ESBL-producing donor and transconjugant strains obtained from filter conjugation experiments were screened for resistance against 31 microbial agents by broth dilution using the MicroScan autoSCAN-4 System (Beckman Coulter Life Sciences, Indianapolis, IN, USA) with the Neg MIC 44 panel. Susceptibility testing was performed according to the manufacturer’s guidelines.
+ Open protocol
+ Expand
4

Automated Blood Culture Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood cultures were processed using the BACTEC 9050 automated instrument (Becton Dickinson, Barelas SA, Greece). Isolates were identified to species level by phenotypic tests and antimicrobial susceptibility was determined with the MicroScan autoSCAN-4 System (Beckman Coulter, Leriva SA, Greece). E tests were used for susceptibility testing of relevant species isolates to colistin, acinetobacter to tigecycline (breakpoint 0.55 mg/l), and staphylococci and enterococci to vancomycin (breakpoint 4 mg/l).
+ Open protocol
+ Expand
5

Identification and Antibiotic Profiling of Salmonella

Check if the same lab product or an alternative is used in the 5 most similar protocols
All isolates were identified and characterized phenotypically using standard biochemical testing (Triple Sugar Iron Agar (TSI), Citrate, Urea, and motility), and the API20E biochemical test kit (Biomerieux, USA). The Kauffmann-White-Le Minor serological scheme using specific commercial antisera was used to identify organisms suspected to be S. Typhi (Difco, United States) [15 ]. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method against amoxicillin-clavulanic acid (AMC), chloramphenicol (CHL), nalidixic acid (NAL), and tetracycline (TET). Minimum Inhibitory Concentrations (MIC) were determined using the MicroScan autoSCAN-4-System (Beckman Coulter) against ampicillin (AMP), cefotaxime (CTX), ceftriaxone (CRO), ceftazidime (CAZ), ciprofloxacin (CIP), and trimethoprim-sulfamethoxazole (SXT), according to the CLSI standards [16 ]. MDR was defined as resistance to ampicillin, chloramphenicol, and co-trimoxazole. We additionally aimed to identify potential Extended-Spectrum Beta-Lactamase (ESBLs) activity mediated by the blaSHV, blaTEM, and blaCTX-M genes by PCR amplification as previously described [17 (link)].
+ Open protocol
+ Expand
6

Bacterial Identification and Antibiotic Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The identification at species level and antibiotic susceptibility testing were carried out using the MicroScan AutoScan4 System (Beckman Coulter, Brea, CA, USA). Bacterial identifications were confirmed by MALDI-TOF mass spectrometry (Vitek MS, BioMérieux, Marcy l’Etoile, France), analyzing colonies from McConckey agar (BioMérieux) (for Enterobacterales and S. maltophilia) or Columbia agar (sheep blood 5%, BioMérieux) (for E. meningoseptica and C. indologenes), incubated overnight at 37 °C. MICs were interpreted according to the 2020 EUCAST breakpoints [30 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!